Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Primary Mediastinal Large B-Cell Lymphoma: Investigation On The Role Of Rituximab and PET During Treatment

Pier Luigi Zinzani, Cinzia Pellegrini, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Federica Quirini, MD, Lisa Argnani, PhD, Vittorio Stefoni, MD

Blood (2013) 122 (21): 3046.

https://doi.org/10.1182/blood.V122.21.3046.3046

Published: 2013

Journal Articles

Sequential R-CHOP and R-FM Chemotherapy Followed By Autologous Stem Cell Transplantation Results In High Rates Of Long Term Remission In Advanced Follicular Lymphoma

Enrico Derenzini, MD, Vittorio Stefoni, MD, Beatrice Casadei, MD, Cinzia Pellegrini, MD, Alessandro Broccoli, MD, Stefano Fanti, MD, Letizia Gandolfi, MD, Giulia Stefani, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD

Blood (2013) 122 (21): 5543.

https://doi.org/10.1182/blood.V122.21.5543.5543

Published: 2013

Journal Articles

Fludarabine, Mitoxantrone and Rituximab (FMR) Regimen in Previously Untreated Patients with Indolent Non-Hodgkin Lymphoma: Efficacy, Safety and PET Data On 285 Patients.

Pier Luigi Zinzani, MD, Cinzia Pellegrini, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Vittorio Stefoni, MD, Beatrice Casadei, MD, Federica Quirini, MD, Lisa Argnani, PhD

Blood (2012) 120 (21): 2736.

https://doi.org/10.1182/blood.V120.21.2736.2736

Published: 2012

Journal Articles

The Role of Interim-PET and Final-PET in the Outcome of Peripheral T-Cell Lymphoma (PTCL) Treated At the Diagnosis with CHOP.

Cinzia Pellegrini, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Vittorio Stefoni, MD, Letizia Gandolfi, MD, Federica Quirini, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD

Blood (2012) 120 (21): 2721.

https://doi.org/10.1182/blood.V120.21.2721.2721

Published: 2012

Journal Articles

Collection of Hematopoietic Stem Cells After Previous Exposure to Ittrium-90 Ibritumumab Tiuxetan (Zevalin) Is Feasible and Does Not Impair Autologous Stem Cell Transplantation Outcome in Follicular Lymphoma.

Enrico Derenzini, MD, Cinzia Pellegrini, MD, Roberto Maglie, Vittorio Stefoni, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Beatrice Casadei, MD, Federica Quirini, MD, Lisa Argnani, PhD, Stefano Fanti, MD, Maria Rosa Motta, PhD, Michele Baccarani, MD, Pier Luigi Zinzani, MD

Blood (2012) 120 (21): 3019.

https://doi.org/10.1182/blood.V120.21.3019.3019

Published: 2012

Journal Articles

FDG-PET in the Serial Assessment of Patients with Lymphoma in Complete Remission.

Pier Luigi Zinzani, MD, PhD, Vittorio Stefoni, MD, Valentina Ambrosini, MD, Enrico Derenzini, MD, Gerardo Musuraca, MD, Enrica Marchi, MD, Lapo Alinari, MD, Mariapaola Fina, MD, Monica Tani, MD, Cinzia Pellegrini, MD, Stefano Fanti, MD, Michele Baccarani, MD

Blood (2007) 110 (11): 216.

https://doi.org/10.1182/blood.V110.11.216.216

Published: 2007

NARROW

Primary Mediastinal Large B-Cell Lymphoma: Investigation On The Role Of Rituximab and PET During Treatment

Sequential R-CHOP and R-FM Chemotherapy Followed By Autologous Stem Cell Transplantation Results In High Rates Of Long Term Remission In Advanced Follicular Lymphoma

Fludarabine, Mitoxantrone and Rituximab (FMR) Regimen in Previously Untreated Patients with Indolent Non-Hodgkin Lymphoma: Efficacy, Safety and PET Data On 285 Patients.

The Role of Interim-PET and Final-PET in the Outcome of Peripheral T-Cell Lymphoma (PTCL) Treated At the Diagnosis with CHOP.

Collection of Hematopoietic Stem Cells After Previous Exposure to Ittrium-90 Ibritumumab Tiuxetan (Zevalin) Is Feasible and Does Not Impair Autologous Stem Cell Transplantation Outcome in Follicular Lymphoma.

FDG-PET in the Serial Assessment of Patients with Lymphoma in Complete Remission.

Email alerts

ASH Publications

American Society of Hematology

Primary Mediastinal Large B-Cell Lymphoma: Investigation On The Role Of Rituximab and PET During Treatment

Sequential R-CHOP and R-FM Chemotherapy Followed By Autologous Stem Cell Transplantation Results In High Rates Of Long Term Remission In Advanced Follicular Lymphoma

Fludarabine, Mitoxantrone and Rituximab (FMR) Regimen in Previously Untreated Patients with Indolent Non-Hodgkin Lymphoma: Efficacy, Safety and PET Data On 285 Patients.

The Role of Interim-PET and Final-PET in the Outcome of Peripheral T-Cell Lymphoma (PTCL) Treated At the Diagnosis with CHOP.

Collection of Hematopoietic Stem Cells After Previous Exposure to Ittrium-90 Ibritumumab Tiuxetan (Zevalin) Is Feasible and Does Not Impair Autologous Stem Cell Transplantation Outcome in Follicular Lymphoma.

FDG-PET in the Serial Assessment of Patients with Lymphoma in Complete Remission.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only